Omega Depot

First clinical trial specific depot in Turkey since 2003

Clinical trial logistics, secure IMP storage, cold-chain distribution, import licensing and depot services across Türkiye since 2003.

Discuss your projectRegulatory intelligence
IMPinvestigational product
IVDkits and reagents
MDmedical devices
End-to-endoperating model

Service map

Plan the clinical supply journey in Türkiye with us

01

Import Licence and Custom Clearance

Permit requirements for study products, devices and equipment are reviewed before dispatch. Product, party and document data are aligned with the customs file so gaps surface early.

02

Controlled Storage

The appropriate temperature zone and inventory status are set from the product profile. Receipt, quarantine, monitoring and movement records follow one operating flow.

03

Distribution across Türkiye

Site request, available stock and delivery window are checked before dispatch. Packing, logger evidence when needed, and proof of delivery close the shipment record.

04

Frequently Asked Questions

We explain the inputs needed for import, storage and clinical-supply decisions. This helps clarify quotation scope and party responsibilities in the first discussion.

Client-anonymized operating experience

The operating scope of past projects

Client names remain private; vaccine studies are shown by name with their own project figures.

15–25 °C · Multi-site programme

Nationwide supply for a smoking-cessation programme

Project scope224 centres · 164,733 participants · 247,435 medicine boxes

The project summary records medicine supply at 15–25 °C across a network involving 400 physicians and 650 assistant healthcare personnel. The box and participant figures belong to this past programme.

For sponsors: Site-level demand, stock units and the delivery calendar should be defined together at the start of scoping.

Distribution service

2–8 °C · Phase 3

Coronovac Phase 3

Project scope24 sites · 26,180 vaccines · 2–8 °C

The Coronovac Phase 3 summary records a 24-site scope for vaccines with a 2–8 °C temperature profile. This quantity belongs to this Phase 3 study alone and is not combined with the other vaccine projects.

For sponsors: Site allocation and cold-chain requirements should be specified for each study and shipment plan.

Storage service

2–8 °C · Phase 3

Turkovac Phase 3

Project scope8 sites · 1,290 people × 2 administrations · 2,580 vaccines

The Turkovac Phase 3 summary lists 2,580 vaccines for two administrations to 1,290 people across eight sites under a 2–8 °C profile. Participant, administration and product counts are distinct planning inputs.

For sponsors: Calculate product demand from the administration schedule, not the site count alone.

Storage service

2–8 °C · Phase 2b

Rapel Phase 2b

Project scope41 sites · 4,340 vaccines · 2–8 °C

The Rapel Phase 2b summary records 4,340 vaccines across a 41-site study scope under a 2–8 °C profile. The breadth of the site network is a planning variable separate from product quantity.

For sponsors: Prepare site-level demand, delivery windows and recipient contacts separately.

Storage service

International routes · Urgent coordination

Urgent international product shipments

Project scope6 routes · 28–35 hours from origin to destination

Past shipment summaries originating in New Delhi, London, Beijing, New York, Hong Kong and Shanghai cover cell-therapy material, research medicines, kits and consumables. The recorded times run from origin to destination; they are not customs-clearance durations.

For sponsors: For an urgent request, share product class, permit status, origin and target delivery time on one timeline.

Customs coordination

Site activation · Equipment and calibration

Equipment support for clinical sites

Project scope7 sites · more than 50 calibration services

The project summary lists ultra-low freezers, incubators, vaccine refrigerators and centrifuges sourced for seven sites. The same document separately reports more than 50 calibration services; device and calibration counts are not combined as one delivery total.

For sponsors: Define technical needs, installation conditions and calibration ownership for each site at the outset.

Equipment and supply sourcing

Source: past project summaries supplied by Omega. Quantities and times describe only the relevant historical examples, not current capacity or a delivery commitment. The source does not distinguish vaccine doses from vials.

Operating model

From uncertainty to a traceable outcome

Every project follows the same control logic, adapted to product and protocol requirements.

  1. 01

    Define scope

    Product, intended use, quantity and target date are confirmed.

  2. 02

    Validate the route

    Regulatory, documentary, temperature and transport requirements are mapped.

  3. 03

    Execute with control

    The operation follows an approved plan, owners and monitoring points.

  4. 04

    Close the records

    Delivery, deviation and accountability records are archived.

Inside the facility

Real infrastructure, real operations

Omega Depot

Plan your next shipment with confidence

Share the product, route and timeline; our team will map a workable operational flow.

Talk to our team